GALMED PHARMACEUTICALS LTD (GLMD) Stock Analyst Ratings

NASDAQ:GLMD • IL0011313900

0.5962 USD
-0.02 (-3.84%)
Last: Mar 3, 2026, 12:33 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to GLMD. The Buy consensus is the weighted average rating of the current analysts ratings.

  • GLMD was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about GLMD.
  • In the previous month the buy percentage consensus was at a similar level.
  • GLMD was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
GLMD Historical Analyst RatingsGLMD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6
GLMD Current Analyst RatingGLMD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2025-04-04 Maxim Group Downgrade Buy -> Hold
2023-07-24 Maxim Group Upgrade Hold -> Buy
2022-08-08 Canaccord Genuity Downgrade Buy -> Hold
2022-08-08 Maxim Group Downgrade Buy -> Hold
2022-05-18 Raymond James Downgrade Outperform -> Market Perform
2022-05-03 Raymond James Maintains Outperform
2022-05-03 HC Wainwright & Co. Downgrade Buy -> Neutral
2021-05-17 Canaccord Genuity Maintains Buy
2021-03-19 HC Wainwright & Co. Maintains Buy

GALMED PHARMACEUTICALS LTD / GLMD FAQ

Can you provide the consensus rating for GALMED PHARMACEUTICALS LTD stock?

The consensus rating for GALMED PHARMACEUTICALS LTD (GLMD) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.